This laboratory has actively pursued the development of ribozymes as potential therapeutic agents for the treatment of HIV-1 infection for the past several years. Recently, ribozyme efficacy was reported against HIV tat and rev targets in retrovirally transduced human T-lymphocytes. Although our pre-clinical studies have demonstrated the feasibility of successfully using ribozymes for the treatment of HIV-1 infection, they also point to the need to continue to improve ribozyme efficacy. The overall goal of the SPIRAT program proposal, of which this project is a part, is the """"""""Transduction Of Hematopoietic Stem Cells Using Ribozymes for Aids."""""""" The goal of this project is the development of a highly effective ribozyme treatment for HIV-1 infection. Project objectives are to improve ribozyme efficacy through (1) basic studies of ribozyme trafficking and (2) information derived from analyses of ribozyme expression and function in a human HIV-1 infected patient population. First, ribozyme trafficking studies will improve ribozyme efficacy by increasing the likelihood that ribozymes and their RNA targets will be present at the same place and time in the complex intracellular environment. The strategy for achieving this co-localization of ribozyme and target will be to use our knowledge of RNA trafficking and localization signals encoded in both cellular and viral RNAs. These signals dictate pathways for RNA travel and final destination in the cell. For this project, several known RNA trafficking and localization signals will be appended to anti-HIV-1 ribozyme transcripts and evaluated for their effect upon anti-HIV-1 ribozyme activity. The most efficacious ribozyme-cis-appended sequences will be incorporated into retroviral and AAV vectors for transduction into human CD34+ cells, and ultimately used in the treatment of HIV-1 infected patients. Second, analyses of anti-HIV-1 ribozyme expression and function in human bone marrow cells, before and after introduction into HIV-1 infected patients, will provide critical insights into ribozyme efficacy in the host environment. The strategy will be to use sensitive, quantitative PCR methodologies to detect ribozyme genes, transcripts and HIV-1 sequences. These methods will not only facilitate the rapid evaluation of ribozyme function in vivo but will also provide valuable information regarding vector transduction frequency.

Project Start
1998-09-01
Project End
2000-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
4
Fiscal Year
1998
Total Cost
Indirect Cost
Name
City of Hope National Medical Center
Department
Type
DUNS #
City
Duarte
State
CA
Country
United States
Zip Code
91010
Krishnan, Amrita (2009) Stem cell transplantation in HIV-infected patients. Curr Opin HIV AIDS 4:11-5
Krishnan, Amrita; Molina, Arturo; Zaia, John et al. (2005) Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 105:874-8
Krishnan, A; Zaia, J; Forman, S J (2003) Should HIV-positive patients with lymphoma be offered stem cell transplants? Bone Marrow Transplant 32:741-8
Krishnan, Amrita; Zaia, John; Molina, Arturo (2002) Stem cell transplantation and gene therapy for HIV-related lymphomas. J Hematother Stem Cell Res 11:765-75
Krishnan, A; Molina, A; Zaia, J et al. (2001) Autologous stem cell transplantation for HIV-associated lymphoma. Blood 98:3857-9
Molina, A; Krishnan, A Y; Nademanee, A et al. (2000) High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy. Cancer 89:680-9
Chatterjee, S; Li, W; Wong, C A et al. (1999) Transduction of primitive human marrow and cord blood-derived hematopoietic progenitor cells with adeno-associated virus vectors. Blood 93:1882-94
Xu, Z D; Oey, L; Mohan, S et al. (1999) Hammerhead ribozyme-mediated cleavage of the human insulin-like growth factor-II ribonucleic acid in vitro and in prostate cancer cells. Endocrinology 140:2134-44
Rossi, J J (1999) Ribozymes, genomics and therapeutics. Chem Biol 6:R33-7
Yam, P Y; Yee, J K; Ito, J I et al. (1998) Comparison of amphotropic and pseudotyped VSV-G retroviral transduction in human CD34+ peripheral blood progenitor cells from adult donors with HIV-1 infection or cancer. Exp Hematol 26:962-8

Showing the most recent 10 out of 12 publications